Doxper

Feature Image 2_From Data to Insights Doxper flow

Customer Success: Serving leading organizations for their RWE, Clinical Trial & KOL outreach needs

  1. Global Leader in Healthcare Analytics

Identifying retrospective longitudinal records with clear clinical outcomes of patients with muscle cramps, who were prescribed the client’s therapy. 

  1. Top 10 MNC Pharma in India

Doxper provided a monthly dataset, based on prescriptions (anonymized Rx), qualifying as “Rx of Interest” generated via telemedicine, EMR or e-pharmacy services on Doxper’s platform. Rx of Interest is defined as containing at least 1 Company brand or 1 competing brand.   

  1. Bangladesh – Medium Sized Pharma Company

Sponsorship of Doxper digital pen solution for 4000 doctors across Bangladesh, in less than a year. Scale up to additional 3000 doctors by December 2022. Doxper is providing a monthly Rx audit of the Company’s brands of interest.

  1. Leading MNC Pharma in the Dermatology space 

Rx insights from existing Doxper panel of dermatologists for various drug-condition and form-drug combinations, in anticipation of brand launch in India.

  1. Global Leader in Healthcare Analytics

Doxper is providing monthly anonymised Rx from its panel of doctors. Doxper is also digitising the company’s own panel of doctors.

  1. Indian MNC Pharma Company 

Real world data project in Africa. Customised and digitised with Doxper a doctor’s regular Rx template with additional structured fields, in lieu of bulky case record form which had poor compliance.

Representative, anonymised sample raw data from Doxper
Representative, anonymised sample raw data from Doxper
From Data to Insights using Doxper
From Data to Insights using Doxper